Osteoporosis is known to occur in patients with kidney transplants, but lim
ited information is available about the prevalence and causes of this compl
ication. We asked all 330 patients with kidney transplants in our unit to p
articipate in this study of whom 165 (50%) agreed to do so. The characteris
tics of the participating patients were similar to the remaining 165 nonpar
ticipants. Seventy of 165 (42%) of the participants were women of whom 40 w
ere postmenopausal in contrast to the men of whom only one was hypogonadal.
Bone mineral density (BMD) was significantly reduced at the radius (Z scor
e, -1.5) and femoral neck (Z score, -0.7), but the lumbar spine was normal.
BMD was lower in women than men at all skeletal sites. Osteoporosis was fo
und in 10-44% and osteopenia was found in 35-50% of women depending on the
site. BMD was related inversely to time since transplantation and cumulativ
e prednisolone dose. Twenty-seven of the 165 (16%) patients had either vert
ebral deformities or a history of a low trauma fracture after transplantati
on. This fracture group consisted of 10/27 (37%) men and 17/27 (63%) women,
of whom 14 were postmenopausal. Fracture patients tended to be older and h
ave a longer duration of renal failure, dialysis, transplantation, greater
cumulative steroid dose, and higher bone resorption markers than the nonfra
cture group. No differences were found for cumulative doses of cyclosporin
or tacrolimus. Logistic regression showed that only duration of dialysis an
d time since transplantation significantly increased fracture risk, with od
ds ratio (OR) for each year of dialysis or transplantation being 1.21 (CI,
1.00-1.48) and 1.14 (CI, 1.05-1.23), respectively. These data show that low
bone density and fractures are common in patients with kidney transplant a
nd are determined by both pre- and posttransplant variables. Fracture risk
was greatest in women, particularly if they were postmenopausal and we reco
mmend that this subgroup is targeted for assessment and treatment.